has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Norepinephrine Bitartrate Injection USP, the company announced today. The shares ...

Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

SSRI medications have come under scrutiny as of late, despite medical experts maintaining they're safe and effective.

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

Biocon’s share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company’s seventh USFDA ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

The companies struck the deal believing Axsome was better equipped to develop the dopamine and norepinephrine reuptake ... the company gained an FDA approval for migraine treatment Symbravo ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy ... rights to Jazz Pharma's dual-acting dopamine and norepinephrine reuptake inhibitor Sunosi (solriamfetol ...

The U.S. Food and Drug Administration (FDA) has also approved SSRIs to treat a number ... include serotonin-norepinephrine reuptake inhibitors such as venlafaxine and duloxetine and atypical ...

Biocon posted a net profit of Rs 659.7 crore, nearly three times higher than Rs 101.4 crore posted in the corresponding ...

Medical conditions can limit which weight loss pills work safely for you. For example, you should avoid phentermine if you ...

Analyses from Randomized Controlled Trials Further Support the Target Engagement and Safety Profile of Ampreloxetine in Neurodegenerative Disease< ...